Study sources | nuViteo

Source record

Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite

Short sleep, hormones and hunger: the Spiegel experiment

See source record and bibliography

Publication year: 2004
DOI: 10.7326/0003-4819-141-11-200412070-00008
PMID: 15583226
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Randomized crossover trial with two two-day conditions; caloric intake and activity were controlled.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
full text verified fields
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the input's identified abstract/full-text fields. A trial identifier linked by an article does not imply a separate registry review.

Source identifiers

PubMed record 15583226
Article DOI: 10.7326/0003-4819-141-11-200412070-00008

Source record

Plasma cortisol levels in response to a cold pressor test did not predict appetite or ad libitum test meal intake in obese women

Acute stress, cortisol and intake: the Geliebter experiment

See source record and bibliography

Publication year: 2012
DOI: 10.1016/j.appet.2012.08.025
PMID: 22983369
PMCID: PMC3490010
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Controlled crossover experiment on two counterbalanced days: a hand in ice-cold water for two minutes versus warm water. Random assignment of the order was not confirmed; do not label it a randomized trial.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
full text verified fields
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the input's identified abstract/full-text fields. A trial identifier linked by an article does not imply a separate registry review.

Source identifiers

PubMed record 22983369
PubMed Central: PMC3490010
Article DOI: 10.1016/j.appet.2012.08.025

Source record

Stress and eating behaviours in healthy adults: a systematic review and meta-analysis

Stress and eating: average associations in the Hill review

See source record and bibliography

Publication year: 2022
DOI: 10.1080/17437199.2021.1923406
PMID: 33913377
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Systematic review and meta-analysis of 54 studies on stress and non-disordered eating.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
full text verified fields
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the input's identified abstract/full-text fields. A trial identifier linked by an article does not imply a separate registry review.

Source identifiers

PubMed record 33913377
Article DOI: 10.1080/17437199.2021.1923406

Source record

Effect of sleep duration on dietary intake, desire to eat, measures of food intake and metabolic hormones: A systematic review of clinical trials

Sleep duration, food intake and hormones: a trial review

See source record and bibliography

Publication year: 2021
DOI: 10.1016/j.clnesp.2021.07.029
PMID: 34620371
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Systematic review of randomized trials; search through July 2020.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
full text verified fields
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the input's identified abstract/full-text fields. A trial identifier linked by an article does not imply a separate registry review.

Source identifiers

PubMed record 34620371
Article DOI: 10.1016/j.clnesp.2021.07.029

Source record

Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial

Sleep extension and energy intake: the Tasali trial

See source record and bibliography

Publication year: 2022
DOI: 10.1001/jamainternmed.2021.8098
PMID: 35129580
PMCID: PMC8822469
Trial registration: NCT02253368
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Single-center randomized trial; two baseline weeks and two intervention weeks in the usual environment; intention-to-treat analysis.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: selected_fields_only
full text verified fields: intervention_duration
pmcid_linkage
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the input's identified abstract/full-text fields. A trial identifier linked by an article does not imply a separate registry review.

Source identifiers

PubMed record 35129580
PubMed Central: PMC8822469
Article DOI: 10.1001/jamainternmed.2021.8098

Source record

Are Emotional Eating and Other Eating Behaviors the Missing Link in the Relationship between Inadequate Sleep and Obesity? A Systematic Review

Sleep and emotional eating: a review of associations

See source record and bibliography

Publication year: 2023
DOI: 10.3390/nu15102286
PMID: 37242168
PMCID: PMC10223856
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Systematic review of cross-sectional, longitudinal and intervention studies; searches in Medline and Scopus, from January 2011 to December 2022.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
full text verified fields
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the input's identified abstract/full-text fields. A trial identifier linked by an article does not imply a separate registry review.

Source identifiers

PubMed record 37242168
PubMed Central: PMC10223856
Article DOI: 10.3390/nu15102286

Source record

Sarcopenia: revised European consensus on definition and diagnosis

Age and ageing · 2019

EWGSOP2: sarcopenia definition and assessment

See source record and bibliography

Authors: Alfonso J Cruz-Jentoft
Gülistan Bahat
Jürgen Bauer
Yves Boirie
Olivier Bruyère
Tommy Cederholm
Cyrus Cooper
Francesco Landi
Yves Rolland
Avan Aihie Sayer
Stéphane M Schneider
Cornel C Sieber
Eva Topinkova
Maurits Vandewoude
Marjolein Visser
Mauro Zamboni
Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2
Publication year: 2019
Online publication date: 2018-09-24
Journal: Age and ageing
Volume: 48
Issue: 1
Pages: 16-31
DOI: 10.1093/ageing/afy169
PMID: 30312372
PMCID: PMC6322506
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Expert consensus updating the European definition and diagnostic approach to sarcopenia; not an intervention trial.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Consulted
Official trial registry consulted: No
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1093/ageing/afy169
PubMed record 30312372
PubMed Central: PMC6322506

Source record

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine · 2023

SELECT: primary cardiovascular composite outcome

See source record and bibliography

Authors: A Michael Lincoff
Kirstine Brown-Frandsen
Helen M Colhoun
John Deanfield
Scott S Emerson
Sille Esbjerg
Søren Hardt-Lindberg
G Kees Hovingh
Steven E Kahn
Robert F Kushner
Ildiko Lingvay
Tugce K Oral
Marie M Michelsen
Jorge Plutzky
Christoffer W Tornøe
Donna H Ryan
SELECT Trial Investigators
Publication year: 2023
Online publication date: 2023-11-11
Journal: The New England journal of medicine
Volume: 389
Issue: 24
Pages: 2221-2232
DOI: 10.1056/NEJMoa2307563
PMID: 37952131
Trial registration: NCT03574597
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Multicenter, randomized, double-blind, placebo-controlled, event-driven superiority trial, phase 3.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
Official trial registry consulted: Yes
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1056/NEJMoa2307563
PubMed record 37952131
Trial registration: NCT03574597
Structured registry: NCT03574597

Source record

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine · 2021

STEP 1: weight change at 68 weeks

See source record and bibliography

Authors: John P H Wilding
Rachel L Batterham
Salvatore Calanna
Melanie Davies
Luc F Van Gaal
Ildiko Lingvay
Barbara M McGowan
Julio Rosenstock
Marie T D Tran
Thomas A Wadden
Sean Wharton
Koutaro Yokote
Niels Zeuthen
Robert F Kushner
STEP 1 Study Group
Publication year: 2021
Online publication date: 2021-02-10
Journal: The New England journal of medicine
Volume: 384
Issue: 11
Pages: 989-1002
DOI: 10.1056/NEJMoa2032183
PMID: 33567185
Trial registration: NCT03548935
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Randomized, double-blind, placebo-controlled trial; allocation 2:1; 68 weeks; phase 3.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
Official trial registry consulted: Yes
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1056/NEJMoa2032183
PubMed record 33567185
Trial registration: NCT03548935
Structured registry: NCT03548935

Source record

Tirzepatide Once Weekly for the Treatment of Obesity

The New England journal of medicine · 2022

SURMOUNT-1: weight change at 72 weeks

See source record and bibliography

Authors: Ania M Jastreboff
Louis J Aronne
Nadia N Ahmad
Sean Wharton
Lisa Connery
Breno Alves
Arihiro Kiyosue
Shuyu Zhang
Bing Liu
Mathijs C Bunck
Adam Stefanski
SURMOUNT-1 Investigators
Publication year: 2022
Online publication date: 2022-06-04
Journal: The New England journal of medicine
Volume: 387
Issue: 3
Pages: 205-216
DOI: 10.1056/NEJMoa2206038
PMID: 35658024
Trial registration: NCT04184622
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Randomized, double-blind, placebo-controlled trial; four parallel groups allocated 1:1:1:1; 72 weeks; phase 3.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
Official trial registry consulted: Yes
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1056/NEJMoa2206038
PubMed record 35658024
Trial registration: NCT04184622
Structured registry: NCT04184622

Source record

Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight

Diabetes, obesity & metabolism · 2025

SURMOUNT-1 DXA: weight, fat and lean soft tissue at 72 weeks

See source record and bibliography

Authors: Michelle Look
Julia P Dunn
Robert F Kushner
Dachuang Cao
Charles Harris
Theresa Hunter Gibble
Adam Stefanski
Ryan Griffin
Publication year: 2025
Online publication date: 2025-02-25
Journal: Diabetes, obesity & metabolism
Volume: 27
Issue: 5
Pages: 2720-2729
DOI: 10.1111/dom.16275
PMID: 39996356
PMCID: PMC11965027
Trial registration: NCT04184622
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Prespecified DXA body-composition substudy nested within randomized SURMOUNT-1; pooled tirzepatide doses; additional post hoc subgroup analyses.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Consulted
Official trial registry consulted: Yes
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1111/dom.16275
PubMed record 39996356
PubMed Central: PMC11965027
Trial registration: NCT04184622
Structured registry: NCT04184622

Source record

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

JAMA · 2024

SURMOUNT-4: continuation or withdrawal after a 36-week tirzepatide lead-in

See source record and bibliography

Authors: Louis J Aronne
Naveed Sattar
Deborah B Horn
Harold E Bays
Sean Wharton
Wen-Yuan Lin
Nadia N Ahmad
Shuyu Zhang
Ran Liao
Mathijs C Bunck
Irina Jouravskaya
Madhumita A Murphy
SURMOUNT-4 Investigators
Publication year: 2024
Online publication date: 2023-12-11
Journal: JAMA
Volume: 331
Issue: 1
Pages: 38-48
DOI: 10.1001/jama.2023.24945
PMID: 38078870
PMCID: PMC10714284
Trial registration: NCT04660643
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Phase 3 trial: 36-week open-label tirzepatide lead-in, followed by 52-week randomized 1:1 double-blind placebo-controlled withdrawal phase.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Consulted
Official trial registry consulted: Yes
Statistical analysis plan consulted: No
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1001/jama.2023.24945
PubMed record 38078870
Source record: jamanetwork.com/journals/jama/fullarticle/2812936
PubMed Central: PMC10714284
Trial registration: NCT04660643
Structured registry: NCT04660643

Source record

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

The New England journal of medicine · 2025

SURMOUNT-5: weight change at 72 weeks

See source record and bibliography

Authors: Louis J Aronne
Deborah Bade Horn
Carel W le Roux
Wayne Ho
Beverly L Falcon
Elisa Gomez Valderas
Sagar Das
Clare J Lee
Leonard C Glass
Cagri Senyucel
Julia P Dunn
SURMOUNT-5 Trial Investigators
Publication year: 2025
Online publication date: 2025-05-11
Journal: The New England journal of medicine
Volume: 393
Issue: 1
Pages: 26-36
DOI: 10.1056/NEJMoa2416394
PMID: 40353578
Trial registration: NCT05822830
Meaning of missing metadata: Null means not supplied or not verified in the selected input; it does not prove that the item does not exist.
Verification date: 2026-11-04

Study design

Randomized, open-label, active-controlled superiority trial; allocation 1:1; 72 weeks; phase 3b.

Verification scope

Bibliographic metadata checked: Yes
Original article abstract consulted: Yes
Full-text consultation: Not consulted
Official trial registry consulted: Yes
Statistical analysis plan consulted: Yes
Verification boundary: Verification is limited to the specific fields and sources consulted; it is not a full systematic appraisal or GRADE rating.

Source identifiers

Article DOI: 10.1056/NEJMoa2416394
PubMed record 40353578
Trial registration: NCT05822830
Structured registry: NCT05822830
Statistical analysis plan: NCT05822830 · SAP_001.pdf

Sources in the curated release

Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite

Study design

Verification scope

Source identifiers

Plasma cortisol levels in response to a cold pressor test did not predict appetite or ad libitum test meal intake in obese women

Study design

Verification scope

Source identifiers

Stress and eating behaviours in healthy adults: a systematic review and meta-analysis

Study design

Verification scope

Source identifiers

Effect of sleep duration on dietary intake, desire to eat, measures of food intake and metabolic hormones: A systematic review of clinical trials

Study design

Verification scope

Source identifiers

Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial

Study design

Verification scope

Source identifiers

Are Emotional Eating and Other Eating Behaviors the Missing Link in the Relationship between Inadequate Sleep and Obesity? A Systematic Review

Study design

Verification scope

Source identifiers

Sarcopenia: revised European consensus on definition and diagnosis

Study design

Verification scope

Source identifiers

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Study design

Verification scope

Source identifiers

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Study design

Verification scope

Source identifiers

Tirzepatide Once Weekly for the Treatment of Obesity

Study design

Verification scope

Source identifiers

Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight

Study design

Verification scope

Source identifiers

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

Study design

Verification scope

Source identifiers

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Study design

Verification scope

Source identifiers